SOD1 and amyotrophic lateral sclerosis: Furthermore, future polytherapy investigations should not be restricted to a single target (i.e., SOD1) and potentially target multiple aspects of ALS pathology such a gliosis, neurotrophic support, neuronal excitability, endoplasmic reticulum stress and apoptosis.